![]() |
|
|
Vol. 302, Issue 3, 957-962, September 2002
Department of Pharmacology, University of Texas Health Science
Center, San Antonio, Texas
The serotonin2C (5-HT2C) receptor couples to
multiple effector mechanisms, including phospholipase
A2-mediated arachidonic acid (AA) release and
phospholipase C-mediated production of inositol phosphates (IP).
Agonist relative efficacy differs depending upon which response (AA
release or IP accumulation) is measured. In this study, we investigated
the characteristics and agonist dependence of rapid desensitization of
5-HT2C receptor-mediated AA release and IP accumulation
measured simultaneously from the same cell population. Pretreatment
with 5-HT reduced the ability of a maximal concentration of 5-HT to
elicit AA release and IP accumulation by about 60%; however, the AA
response desensitized more rapidly (t1/2 = 1.3 min) than the IP response
(t1/2 = 6.9 min). In addition, desensitization of the IP response was more sensitive (occurred at
lower receptor occupancy levels) than the AA response. Moreover, in
response to submaximal 5-HT concentrations, after an initial transient
desensitization, the AA response was enhanced by up to ~250%. After
maximal desensitization, both responses recovered, but recovery of the
AA response was complete and faster than that for IP. Desensitization
of both responses was also agonist-dependent, and the capacity of
agonists to elicit desensitization was not related to their efficacy to
activate signaling. These data suggest that desensitization of the
5-HT2C receptor system is both agonist- and effector
pathway-dependent and underscore the need to study multiple cellular
responses to multiple agonists to understand receptor-mediated
signaling systems.
This article has been cited by other articles:
![]() |
P. R. Moya, K. A. Berg, M. A. Gutierrez-Hernandez, P. Saez-Briones, M. Reyes-Parada, B. K. Cassels, and W. P. Clarke Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1054 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Urban, W. P. Clarke, M. von Zastrow, D. E. Nichols, B. Kobilka, H. Weinstein, J. A. Javitch, B. L. Roth, A. Christopoulos, P. M. Sexton, et al. Functional Selectivity and Classical Concepts of Quantitative Pharmacology J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 1 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Berg, S. Navailles, T. A. Sanchez, Y. M. Silva, M. D. Wood, U. Spampinato, and W. P. Clarke J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 260 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maudsley, B. Martin, and L. M. Luttrell The Origins of Diversity and Specificity in G Protein-Coupled Receptor Signaling J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 485 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Clarke What's for Lunch at the Conformational Cafeteria? Mol. Pharmacol., June 1, 2005; 67(6): 1819 - 1821. [Abstract] [Full Text] [PDF] |
||||